Today, the Grünenthal group announced the takeover of Adhesys Medical GmbH and its American subsidiary Adhesys Medical Inc. Adhesys Medical, a start-up company for medical products, develops tissue adhesives for surgery use. With this takeover Grünenthal secured the worldwide production and marketing rights of an innovative pipeline of surgery tissue adhesives as well as the underlying technology platform. Within the next twelve months the first innovative topical skin adhesives are expected to obtain the Europe-wide CE-label.

GSK Stockmann comprehensively advised the shareholders of Adhesys Medical GmbH on structuring and negotiating  the entire sale, including  a complex share purchase contract.

About Adhesys Medical:
Adhesys Medical was founded in Aachen, Germany in 2013 by Dr. Heike Heckroth, the inventor of the technology, Prof. Dr. René Tolba, Prof. Dr. Malte Brettel, Marius Rosenberg and Alexander Schueller. Adhesys Medical is based on a unique polyurethane technology platform which was developed since 2007 to introduce innovative surgery tissue adhesives onto the market.

Advisor shareholder Adhesys Medical GmbH:
GSK Stockmann: Max Wilmanns, Dr. Andreas Peters (both Lead, Corporate/M&A), Dr. Dirk Koch (Tax), Dr. Philipp Kuhn (Employment), Birgit Wöhren (Dispute Resolution); Associates: Stephanie Stimpel (Corporate/M&A), Matthias Kaiser (Employment).

Advisor Adhesys Medical to US topics:
Ropes & Gray, Boston (USA)